According to a new market report published by Lucintel, the future of the genomic and proteomic tool market looks promising with opportunities in the agriculture and animal husbandry, drug discovery, forensics, proteogenomics research, disease identification, diagnostics and control applications. The global genomic and proteomic tool market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are increasing prevalence of cancer, diabetes, and cardiovascular diseases, rising demand for personalized medicines, and increasing research activities related to genomics and proteomics.
In this market, sample preparation, electrophoresis, biochips and microarrays, chromatography, mass spectrometry, thermal cyclers, and next-generation sequencing are the major types. Lucintel forecasts that next-generation sequencing will remain the fastest growing segment over the forecast period due to its declining cost and increasing clinical opportunities.
Within this market, proteogenomic research will remain the largest segment by application over the forecast period due to increasing research and development expenditure related to proteomics and rising number of genomic research projects.
North America will remain the largest region over the forecast period due to increasing prevalance of cancer, increasing research activities related to genomics and proteomics, and presence of advanced healthcare infrastructure & research facilities in the region.
3Billion, Bio-Rad Laboratories, GE Healthcare, Novogene, Qiagen, Thermo Fisher Scientific, and Waters are among the major suppliers in the global genomic and proteomic tool market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global genomic and proteomic tool market by technology and product, type, application, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Genomic and Proteomic Tool Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global genomic and proteomic tool market by technology and product, type, application, and region as follows:
By Technology and Product Form [Value ($ Million) shipment analysis for 2014 – 2025]:
Sequencing Technologies
Sangers Sequencing & Next Generation Sequencing
PCR (Polymerase Chain Reaction) Technologies
Flow Cytometry
Mass Spectrometry
Nucleic Acid Sample Preparation Technologies
Separation Technologies
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
Sample Preparation
Electrophoresis
Biochips and Microarrays
Chromatography
Mass Spectrometry
Thermal Cyclers
Next-Generation Sequencing
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Agriculture and Animal Husbandry
Drug Discovery
Forensics
Proteogenomics Research
Disease Identification
Diagnostics and Control
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.